MARY SCHMAUDER: Open Payments
NPI 1245940048 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,418 in 124 payments from 18 companies in 2025. Trend: 2023 $1,516 · 2024 $2,289 · 2025 $2,418
Food & beverage: $2,321Education: $97
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $517 |
| Incyte Corporation | 20 | $478 |
| ABBVIE INC. | 30 | $340 |
| UCB, Inc. | 13 | $210 |
| Regeneron Healthcare Solutions, Inc. | 9 | $192 |
| Lilly USA, LLC | 5 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $97 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $89 |
| Amgen Inc. | 3 | $78 |
| Galderma Laboratories, L.P. | 4 | $65 |
Products named: TREMFYA, OPZELURA, SKYRIZI, Bimzelx, DUPIXENT, RINVOQ, TALTZ, OTEZLA.
Industry payments across VA — which companies pay providers there.
